Based on the GSE153610 dataset (Figure 10K and Table S1), compared with recovered COVID-19 patients without cancer, TNFSF10 were upregulated in monocytes of cancer patients infected with SARS-CoV-2, while IFITM2 were downregulated. Here, IFITM2 is linked to cancer.